Evidence map›Paper›PMID 38657239›Full record

ArticleJMIR research protocols2024

Tobacco Smoking or Nicotine Phenotype and Severity of Clinical Presentation at the Emergency Department (SMOPHED): Protocol for a Noninterventional Observational Study.

Davide Campagna, Konstantinos Farsalinos, Giorgio Costantino, Giuseppe Carpinteri, Pasquale Caponnetto, Francesca Cucuzza, Riccardo Polosa, SMOPHED Study Group

Open access · goldAbstract read
In one paragraph

Article in JMIR research protocols, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 97% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Davide Campagna *Department of Clinical and Experimental Medicine, University of Catania, Catania, Italy.ORCID 0000-0001-8440-0121
Konstantinos Farsalinos *Department of Public and Community Health, School of Public Health, University of West Attica, Athens, Greece.ORCID 0000-0001-6839-4710
Giorgio Costantino *Scientific Institute for Research, Hospitalization and Healthcare Ca' Granda Ospedale Maggiore Policlinico, Unità Operativa Complessa Pronto Soccorso e Medicina d'Urgenza, University of Milan, Milan, Italy.ORCID 0000-0002-6391-3849
Giuseppe Carpinteri *Emergency Department, Policlinico Teaching Hospital, Catania, Italy.ORCID 0000-0001-9280-9621
Pasquale Caponnetto *Department of Educational Sciences, Section of Psychology, University of Catania, Catania, Italy.ORCID 0000-0001-7414-155X
Francesca Cucuzza *Emergency Department, Policlinico Teaching Hospital, Catania, Italy.ORCID 0009-0002-8517-4298
Riccardo Polosa *Department of Clinical and Experimental Medicine, University of Catania, Catania, Italy.ORCID 0000-0002-8450-5721
SMOPHED Study Group *See Acknowledgments, .
University of Catania · ITPoliclinico Universitario di Catania · ITFondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico · ITUniversity of West Attica · GR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIn the last few years, several nicotine products have become available as alternatives to smoking tobacco. While laboratory and limited clinical studies suggest that these devices are less toxic compared to classic tobacco cigarettes, very little is known about their epidemiological impact. Visiting the emergency department (ED) often represents the first or even the only contact of patients with the health care system. Therefore, a study conducted at the ED to assess the impact of these products on health can be reliable and reflect a real-life setting.

objectiveThe aim of this noninterventional observational study (SMOPHED study) is to analyze the association between the severity of clinical presentation observed during ED visits among patients using various nicotine products and the subsequent outcomes, specifically hospitalization and mortality.

methodsOutcomes (hospitalization and mortality in the ED) will be examined in relation to various patterns of nicotine products use. We plan to enroll approximately 2000 participants during triage at the ED. These individuals will be characterized based on their patterns of tobacco and nicotine consumption, identified through a specific questionnaire. This categorization will allow for a detailed analysis of how different usage patterns of nicotine products correlate with the clinical diagnosis made during the ED visits and the consequent outcomes.

resultsEnrollment into the study started in March 2024. We enrolled a total of 901 participants in 1 month (approximately 300 potential participants did not provide the informed consent to participate). The data will be analyzed by a statistician as soon as the database is completed. Full data will be published by December 2024.

conclusionsThere is substantial debate about the harm reduction potential of alternative nicotine products in terms of their smoking-cessation and risk-reduction potential. This study represents an opportunity to document epidemiological data on the link between the use of different types of nicotine products and disease diagnosis and severity during an ED visit, and thus evaluate the harm reduction potential claims for these products. INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID): PRR1-10.2196/54041.

Indexed as

Emergency Service, HospitalAdultFemaleHospitalizationHumansMaleMiddle AgedNicotineObservational Studies as TopicPhenotypeSeverity of Illness IndexTobacco SmokingNicotineelectronic cigarettesemergency departmentheated tobacco productsNational Early Warning ScoreNEWSnicotine/tobacco usesmoking

Identifiers

PMID38657239
PMCPMC11079756
OpenAlexW4391967883

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.